99% USP/Ep/Bp Weight Loss Is The Best Choice GLP-1 Semaqlutide CAS. 910463-68-2

• CAS No.: 910463-68-2
• Formula: Na
• EINECS: Na
• Type: Pharmaceutical Intermediates
• Appearance: Powder
• Quality: Industrial
• Model NO.: dongfang
• Colour: White
• Usage: Cosmetic Raw Materials
• Particle Size: 100% Pass 80 Mesh
• Product Name: Semaqlutide
• Application: Weight Loss
• Quality Guarantee Period: 2 Years
• Transport Package: Bottle
• Specification: 10g /bottle
• Trademark: dongfang
• Origin: China
• Production Capacity: 100kg Per Month

Product Description

Semaglutide is a new generation GLP-1 (glucagon-like peptide-1) analogues. Semaglutide is a long-acting dosage form based on the basic structure of liraglutide, which is more effective in the treatment of type 2 diabetes mellitus. Compared with lilarlutide, somalutide has a longer aliphobic chain and an increased hydrophobicity, but somalutide is modified with a short chain of PEG, and its hydrophilicity is greatly enhanced.PEG modification can not only tightly bind to albumin, cover up the DPP-4 enzymatic hydrolysis site, but also reduce renal excretion, prolong the biological half-life, and achieve the effect of long circulation.


Semaglutide (USAN; trade name Oze mpic) is a pharmaceutical drug in development by a Danish company Novo Nordisk for the treatment of type 2 diabetes. It is marketed by the name Oze mpic. As a glucagon-like peptide-1 receptor agonist, it lowers the blood sugar level by increasing the production.It was discovered in 2012, by a team of researchers at Novo Nordisk as a longer-acting alternative to liraglutide. Clinical trials were started in 2015, and phase 3 was completed in 2016. FDA approval was applied in December 2016, and in October 2017 FDA Advisory Committee voted 16-0 in favour. It can be used as both injection-type or oral-type drug.
Researchers at the University of Leeds reported in 2017 that it can also be used for the treatment of obesity. It reduces hunger, food craving and body fat.